Explore a curated snapshot of registered cell and regenerative-medicine studies, then continue to the official registry to confirm recruitment, eligibility and study-site details.
Registry snapshot checked 22 July 2026Always confirm the current status with the listed study site.
These records are selected for geographic and clinical breadth. They are not a complete inventory and do not indicate endorsement, safety, effectiveness or patient eligibility.
26 records shown
Study-wide and individual-site status may differParkinson disease
Transverse myelitis
Spinal cord injury
Knee osteoarthritis
Ischemic cardiomyopathy
Systemic sclerosis
SLE and lupus nephritis
Type 2 diabetes
Retinitis pigmentosa
Ischemic heart failure
Liver cirrhosis
COPD
Acute ischemic stroke
Diabetic nephropathy
Crohn's disease
Multiple system atrophy
Type 1 diabetes
Amyotrophic lateral sclerosis
Alzheimer disease
Terminal heart failure
Knee osteoarthritis
Liver cirrhosis
Spinal cord injury
Biliary atresia and liver fibrosis
Amyotrophic lateral sclerosis
Multiple sclerosis
Reset the filters or search the official global registries below.
WHO-recognized primary registries and government databases provide the authoritative record. Use more than one registry when searching internationally.
Search records supplied by the WHO registry network and follow each result to its original registry.
Search study status, sponsor, eligibility and individual study locations.
Current medicinal-product trials under the EU Clinical Trials Regulation.
Plain-language summaries, protocols, results and study outputs.
Interventional and observational studies with detailed recruitment filters.
Regulated studies including dedicated regenerative-medicine classifications.
Korean interventional and observational research in Korean and English.
Clinical studies conducted in India with phase and recruitment filters.
Clinical trials and observational research conducted in Thailand.
Search by condition, intervention, phase, city, hospital and recruitment status.
Brazil-focused records available in Portuguese and English.
Pan-African trial search with country, status and map filters.
Interventional and observational studies with site and status search.
Iranian WHO Primary Registry with advanced search.
Authorized trials conducted in Peru, including historical records.
Sri Lankan trial records with progress reports.
Authorized Phase I–III pharmaceutical and biological drug trials; “ongoing” does not confirm recruitment.
Participation should begin with an official record, an active study contact and an informed-consent conversation you understand.
A study may be recruiting overall while a location near you is closed or not yet open.
Read inclusion criteria, exclusions, study design, interventions and the purpose of the phase.
Informed consent is an ongoing conversation. Ask about risks, alternatives, travel, costs, privacy and your right to withdraw.
Submissions are reviewed by our editorial team before anything is considered for publication. An official public record is required; submissions are never published automatically.
Make this page easier to read and navigate. Your choices stay on this device.
No adjustments activeReady to read this page.
Speech uses a voice already installed on your device. SCT does not receive or store what is spoken. Keep browser-service voices off when you require on-device processing.
How we support access and how to contact us.
We want every visitor to stemcellthailand.org to be able to find, read and act on the information here. That includes people who browse with assistive technology and people who need to change how a page looks before they can read it comfortably.
We treat accessibility as continuing maintenance rather than a one time project. We use the Web Content Accessibility Guidelines (WCAG) as our working reference and review accessibility during design, development and content review.
We do not claim that every page meets every guideline at all times. Parts of this site carry older medical content, embedded video or third-party services whose behavior sits outside our direct control. Where we find a barrier, we fix it and record the fix.
The panel on this site runs entirely in your browser. It can:
Reading aloud is a convenience for visitors who do not use assistive technology. It is not a screen reader. If you use VoiceOver, TalkBack, Narrator, NVDA or JAWS, those remain the right way to browse this site, and our work goes into the underlying page structure so they perform well. A settings panel cannot substitute for accessible markup, and we do not present it as one.
The panel creates no account, sets no tracking cookie and sends no reading preference to us. Your choices are stored in your own browser and stay on your device. Spoken reading uses the speech voices your browser or operating system already provides, so we never receive or store what is read aloud.
If you meet an accessibility barrier, or you need information from this site in another format, email info@stemcellthailand.org. Tell us the page you were on and what you were trying to do. We aim to reply within three to five business days, and we can provide the information through another channel where that helps.
Please do not include private medical details in an accessibility request.
